TY - JOUR T1 - Use of Venous Excess UltraSound (VExUS) score in hyponatraemia management in critically ill patient JF - BMJ Case Reports JO - BMJ Case Reports DO - 10.1136/bcr-2021-246995 VL - 15 IS - 2 SP - e246995 AU - Rita Varudo AU - Inês Pimenta AU - Jacobo Bacariza Blanco AU - Filipe André Gonzalez Y1 - 2022/02/01 UR - http://casereports.bmj.com/content/15/2/e246995.abstract N2 - Hyponatraemia is the most prevalent electrolyte disorder in the neurocritical care setting and is associated with a significant morbimortality. Cerebral salt wasting and inappropriate antidiuretic hormone secretion syndrome have been classically described as the two most frequent entities responsible for hyponatraemia in neurocritical care patients. An accurate aetiological diagnosis of hypotonic hyponatraemia requires a proper volume status assessment. Nevertheless, determination of volume status based on physical examination, laboratory findings and imaging modalities have several limitations and can lead to improperly diagnosis and hyponatraemia mismanagement. Point-of-care ultrasound (POCUS), specifically Venous Excess UltraSound (VExUS) score, is a fast and valuable tool to evaluate venous congestion at the bedside and identify hypervolaemia, helping the physicians in therapeutic decision making in a patient with hyponatraemia. We report a case where the use of POCUS, and more specifically VExUS, can be helpful in volume status assessment, complementing the complex management of multifactorial hyponatraemia in a neurocritical patient. ER -